Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |